Literature DB >> 11975978

HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm.

René J Duquesnoy1.   

Abstract

This report describes an algorithm for identifying acceptable HLA antigens for highly alloimmunized patients without the need for extensive serum screening. This algorithm is based on the concept that immunogenic epitopes are represented by amino acid triplets on exposed parts of protein sequences of human leukocyte antigen chains (HLA-A, HLA-B, and HLA-C) accessible to alloantibodies. A computer program (HLAMatchmaker) has been developed to determine class I HLA compatibility at the molecular level. It makes intralocus and interlocus comparisons of polymorphic triplets in sequence positions to determine the spectrum of non-shared triplets on donor HLA antigens. In most cases is it possible to identify certain mismatched HLA antigens that share all their polymorphic triplets with the patient's HLA antigens and could therefore, be considered fully compatible. HLAMatchmaker permits also the identification of additional mismatches that are acceptable as determined from the triplet information on HLA-typed panel cells that do not react with patient's serum.HLAMatchmaker provides an assessment of donor-recipient HLA compatibility at the structural level and this algorithm is different from conventional methods based on the mere counting of numbers of mismatched HLA antigens or CREGs. This donor selection strategy is suitable especially for allosensitized patients in need of a compatible transplant or platelet transfusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11975978     DOI: 10.1016/s0198-8859(02)00382-8

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  45 in total

1.  A structurally based approach to determine HLA compatibility at the humoral immune level.

Authors:  Rene J Duquesnoy
Journal:  Hum Immunol       Date:  2006-09-01       Impact factor: 2.850

Review 2.  HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation.

Authors:  Adriana Zeevi; Alin Girnita; Rene Duquesnoy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.

Authors:  Rene J Duquesnoy; Medhat Askar
Journal:  Hum Immunol       Date:  2006-10-30       Impact factor: 2.850

Review 4.  Moving Biomarkers toward Clinical Implementation in Kidney Transplantation.

Authors:  Madhav C Menon; Barbara Murphy; Peter S Heeger
Journal:  J Am Soc Nephrol       Date:  2017-01-06       Impact factor: 10.121

5.  Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation.

Authors:  Pan Liu; Tomokazu Souma; Andrew Zu-Sern Wei; Xueying Xie; Xunrong Luo; Jing Jin
Journal:  J Vis Exp       Date:  2017-09-06       Impact factor: 1.355

Review 6.  HLA epitope matching in pediatric renal transplantation.

Authors:  Matthew P Sypek; Peter Hughes; Joshua Y Kausman
Journal:  Pediatr Nephrol       Date:  2016-12-19       Impact factor: 3.714

7.  Why can sensitization by an HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1?

Authors:  Marilyn Marrari; Rene J Duquesnoy
Journal:  Hum Immunol       Date:  2009-03-09       Impact factor: 2.850

8.  Low Hydrophobic Mismatch Scores Calculated for HLA-A/B/DR/DQ Loci Improve Kidney Allograft Survival.

Authors:  Dulat Bekbolsynov; Beata Mierzejewska; Jadwiga Borucka; Robert S Liwski; Anna L Greenshields; Joshua Breidenbach; Bradley Gehring; Shravan Leonard-Murali; Sadik A Khuder; Michael Rees; Robert C Green; Stanislaw M Stepkowski
Journal:  Front Immunol       Date:  2020-10-29       Impact factor: 7.561

Review 9.  Evolution of HLA antibody detection: technology emulating biology.

Authors:  Robert A Bray; Peter W Nickerson; Ronald H Kerman; Howard M Gebel
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

10.  HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors.

Authors:  Rene Duquesnoy; Stephen Spellman; Michael Haagenson; Tao Wang; Mary M Horowitz; Machteld Oudshoorn
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.